Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063481) titled 'A Study of Community Pharmacist Support for Home Blood Pressure Using a Blood Pressure Follow-up Sheet' on Nov. 1.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - MEDICAL SYSTEM NETWORK Co.,Ltd Nanohana East Japan Nanohana Pharmacy Satsuki Store

Condition: Condition - Hypertension Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To implement blood pressure management in community pharmacies in accordance with the 2025 Japanese guidelines for the management and treatment of hypertension, community pharmacists use a blood pressure follow-up sheet to systematically assess home blood pressure, medication use, subjective symptoms, and other relevant factors, and provide information to physicians as needed. This study aims to evaluate changes in home blood pressure before and after the intervention and to examine the attainment of blood pressure targets, prescription changes, recommendations made by pharmacists to physicians, and challenges associated with the use of the follow-up sheet Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Blood pressure management support by community pharmacists using a blood pressure follow-up sheet

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Patients receiving medication indicated for hypertension who were able to measure and manage home blood pressure. 2. Patients aged 18 years or older who personally consented to participate in the study. 3. Patients with home blood pressure of at least 125/75 mmHg or office blood pressure of at least 130/80 mmHg at the start of the intervention. Key exclusion criteria - 1. Patients who did not consent to participation or withdrew consent. 2. Patients whose medication was collected by a proxy without the patient visiting the pharmacy. 3. Patients judged by the pharmacist to be unable to undergo the sheet-based intervention or medication follow-up because of cognitive impairment. 4. Patients unable to measure or record blood pressure. Target Size - 100

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2026 Year 03 Month 25 Day Date of IRB - 2026 Year 03 Month 25 Day Anticipated trial start date - 2026 Year 04 Month 01 Day Last follow-up date - 2026 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072590

Disclaimer: Curated by HT Syndication.